Refractory hypothyroidism in children: an overview
- 5 September 2024
- journal article
- research article
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 37 (10) , 841-849
Abstract
Refractory hypothyroidism (RF) defined as raised serum levels of thyroid stimulating hormone (TSH) above upper limit of the reference range with or without the persistence of hypothyroid symptoms following a 6-week interval after the dosage was last increased to upper limits of dose per age. The most common cause of RH is inadequate compliance. In addition, diet, concomitant medication interactions, and gastrointestinal diseases can all result in l -thyroxine (LT4) malabsorption, which can cause RH. Moreover, weight gain, switching brands of LT4, poor storage of LT4, chronic liver disorders, cystic fibrosis, nephrotic syndrome, consumptive hypothyroidism, Addison’s disease are significant contributors to RF in children. RH in children is frequently asymptomatic, when symptoms do occur, they are typically minor and resemble those of hypothyroidism. It is essential to identify RH early and treat its underlying cause in order to avoid overusing LT4, which can lead to cardiac and bone problems. Endocrinologists should handle children who they suspect of having RH methodically after making sure there is enough compliance. Searching for undiagnosed illnesses and/or other factors that can affect LT4 absorption could be part of this. We present this review after an extensive literature search and long-standing clinical experience. This review’s objective is to shed light on the causes, clinical manifestations, investigations, and treatment of RH in children.Keywords
This publication has 85 references indexed in Scilit:
- Strategies for Improving Adherence to Pediatric Medical Regimens2023
- Prevalence of gastrointestinal disorders having an impact on tablet levothyroxine absorption: should this formulation still be considered as the first-line therapy?Endocrine, 2020
- Levothyroxine Dose Adjustment to Optimise Therapy Throughout a Patient’s LifetimeAdvances in Therapy, 2019
- Evaluation and management of the child with hypothyroidismWorld Journal of Pediatrics, 2019
- Malabsorption blood test: Assessing fat absorption in patients with cystic fibrosis and pancreatic insufficiencyThe Journal of Clinical Pharmacology, 2015
- Drug Interactions with Levothyroxine Therapy in Patients with Hypothyroidism: Observational Study in General PracticeClinical Drug Investigation, 2015
- The Excess Risk of Major Osteoporotic Fractures in Hypothyroidism Is Driven by Cumulative Hyperthyroid as Opposed to Hypothyroid Time: An Observational Register-Based Time-Resolved Cohort AnalysisJournal of Bone and Mineral Research, 2014
- Thyroxine treatment: absorption, malabsorption, and novel therapeutic approachesEndocrine, 2012
- Thyroid-stimulating hormone (thyrotropin)-secretion pituitary adenoma in an 8-year-old boy: case reportPituitary, 2010
- Thyroid function in children with cystic fibrosisEuropean Journal of Pediatrics, 1982